These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20430449)

  • 1. Cerebral interleukin-15 shows upregulation and beneficial effects in experimental autoimmune encephalomyelitis.
    Wu X; Pan W; He Y; Hsuchou H; Kastin AJ
    J Neuroimmunol; 2010 Jun; 223(1-2):65-72. PubMed ID: 20430449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cessation of blood-to-brain influx of interleukin-15 during development of EAE.
    Hsuchou H; Pan W; Wu X; Kastin AJ
    J Cereb Blood Flow Metab; 2009 Sep; 29(9):1568-78. PubMed ID: 19536071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A2A adenosine receptor signaling in lymphocytes and the central nervous system regulates inflammation during experimental autoimmune encephalomyelitis.
    Mills JH; Kim DG; Krenz A; Chen JF; Bynoe MS
    J Immunol; 2012 Jun; 188(11):5713-22. PubMed ID: 22529293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-15 affects serotonin system and exerts antidepressive effects through IL15Rα receptor.
    Wu X; Hsuchou H; Kastin AJ; He Y; Khan RS; Stone KP; Cash MS; Pan W
    Psychoneuroendocrinology; 2011 Feb; 36(2):266-78. PubMed ID: 20724079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential role of interleukin-15 receptor in normal anxiety behavior.
    Wu X; He Y; Hsuchou H; Kastin AJ; Rood JC; Pan W
    Brain Behav Immun; 2010 Nov; 24(8):1340-6. PubMed ID: 20600810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD1-dependent regulation of chronic central nervous system inflammation in experimental autoimmune encephalomyelitis.
    Teige A; Teige I; Lavasani S; Bockermann R; Mondoc E; Holmdahl R; Issazadeh-Navikas S
    J Immunol; 2004 Jan; 172(1):186-94. PubMed ID: 14688325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.
    Klein RS; Izikson L; Means T; Gibson HD; Lin E; Sobel RA; Weiner HL; Luster AD
    J Immunol; 2004 Jan; 172(1):550-9. PubMed ID: 14688366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis.
    Carboni S; Aboul-Enein F; Waltzinger C; Killeen N; Lassmann H; Peña-Rossi C
    J Neuroimmunol; 2003 Dec; 145(1-2):1-11. PubMed ID: 14644025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-33 is released in spinal cord and suppresses experimental autoimmune encephalomyelitis in mice.
    Chen H; Sun Y; Lai L; Wu H; Xiao Y; Ming B; Gao M; Zou H; Xiong P; Xu Y; Tan Z; Gong F; Zheng F
    Neuroscience; 2015 Nov; 308():157-68. PubMed ID: 26363151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system.
    Zhang GX; Gran B; Yu S; Li J; Siglienti I; Chen X; Kamoun M; Rostami A
    J Immunol; 2003 Feb; 170(4):2153-60. PubMed ID: 12574388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid endocytosis of interleukin-15 by cerebral endothelia.
    Stone KP; Kastin AJ; Hsuchou H; Yu C; Pan W
    J Neurochem; 2011 Feb; 116(4):544-53. PubMed ID: 21155807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
    Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
    Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain interleukin-15 in neuroinflammation and behavior.
    Pan W; Wu X; He Y; Hsuchou H; Huang EY; Mishra PK; Kastin AJ
    Neurosci Biobehav Rev; 2013 Feb; 37(2):184-92. PubMed ID: 23201098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and signaling of novel IL15Ralpha splicing variants in cerebral endothelial cells of the blood-brain barrier.
    Wu X; Pan W; Stone KP; Zhang Y; Hsuchou H; Kastin AJ
    J Neurochem; 2010 Jul; 114(1):122-9. PubMed ID: 20374432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of IL-4Rα in the BALB/c mouse is associated with altered lesion topography and susceptibility to experimental autoimmune encephalomyelitis.
    Orian JM; Keating P; Downs LL; Hale MW; Jiang X; Pham H; LaFlamme AC
    Autoimmunity; 2015 Jun; 48(4):208-21. PubMed ID: 25427822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines.
    Lees JR; Iwakura Y; Russell JH
    J Immunol; 2008 Jun; 180(12):8066-72. PubMed ID: 18523270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8.
    Sánchez-Fernández A; Zandee S; Amo-Aparicio J; Charabati M; Prat A; Garlanda C; Eisenmesser EZ; Dinarello CA; López-Vales R
    Theranostics; 2021; 11(1):1-13. PubMed ID: 33391457
    [No Abstract]   [Full Text] [Related]  

  • 18. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
    Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
    Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination.
    Gran B; Zhang GX; Yu S; Li J; Chen XH; Ventura ES; Kamoun M; Rostami A
    J Immunol; 2002 Dec; 169(12):7104-10. PubMed ID: 12471147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
    Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
    J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.